Common use of Filing of Joint Patents Clause in Contracts

Filing of Joint Patents. The Parties will cooperate with one another with respect to the filing, prosecution and maintenance of all Joint Patents. The Parties will designate one of the Parties to be responsible for, and to initially bear the expense of, the preparation, filing, prosecution, and maintenance of a Joint Patent, provided that the responsible Party will be entitled to reimbursement by the other Party of an equal share of the responsible Party’s expenses. The Parties agree that for all Joint Patents for Product-Specific Technology, OncoGenex will be deemed to be the responsible Party for the purposes of this Section 6.2.3, and will bear all expenses for the preparation, filing, prosecution and maintenance of such Patents. With the exception of Joint Patent to Product-Specific Technology, which will be as set forth in Section 6.2.2, the responsible Party will consult with the other Party as to the preparation, filing, prosecution, and maintenance of such Joint Patent reasonably prior to any deadline or action with the U.S. Patent & Trademark Office or any foreign patent office, and will furnish to the other Party copies of all relevant documents reasonably in advance of such consultation. For the life of the Joint Patents, the Parties will mutually agree upon all Joint Patent filings. Notwithstanding the foregoing, if Isis is unilaterally developing and commercializing the Product in accordance with Section 9.2, Isis will have the first right to file, prosecute and maintain any Joint Patents to Product-Specific Technology at its expense, provided that if Isis elects not (a) to pursue the filing, prosecution or maintenance of such a Joint Patent in a particular country, or (b) to take any other action with respect to such Joint Patent in a particular country that is necessary or reasonably useful to establish or preserve rights thereto, then in each such case Isis will so notify OncoGenex promptly in writing and in good time to enable OncoGenex to meet any deadlines by which an action must be taken to establish or preserve any rights in such Joint Technology in such country, and OncoGenex will have the right, but not the obligation, to pursue the filing or registration, or support the continued prosecution or maintenance, of such Joint Patent, at its expense in such country.

Filing of Joint Patents. The Subject to Section 7.2.5, the Parties will cooperate with one another with respect to the filing, prosecution and maintenance of all Joint Patents. The Parties will designate one of the Parties to be responsible for, and to initially bear the expense of, the preparation, filing, prosecution, and maintenance of a Joint Patent, provided that the responsible Party will be entitled to reimbursement by the other Party of an equal share of the responsible Party’s expenses. The Parties agree that for all expenses as follows: i) Proportionate Share of such expenses if the Joint Patents for Patent is a Product-Specific TechnologyTechnology Patent, OncoGenex will be deemed to be the responsible Party for the purposes of this Section 6.2.3, and will bear all expenses for the preparation, filing, prosecution and maintenance or ii) equal sharing of such Patents. With expenses if the exception of Joint Patent to is not a Product-Specific Technology, which will be as set forth in Section 6.2.2, the Technology Patent. The responsible Party will consult with the other Party as to the preparation, filing, prosecution, and maintenance of such Joint Patent reasonably prior to any deadline or action with the U.S. Patent & Trademark Office or any foreign patent office, and will furnish to the other Party party copies of all relevant documents reasonably in advance of such consultation. For the life of the Joint Patents, the Parties will mutually agree upon all Joint Patent filings. Notwithstanding Not withstanding the foregoing, if Isis one Party is unilaterally developing and commercializing the Product in accordance with Section 9.22.3.4, Isis section 2.3.5, or Section 2.4.3, or Article 9, the Party continuing with the development and commercialization of the Product (for purposes of this Section only, the “Continuing Party”) will have the first right to file, prosecute and maintain any Joint Patents to Product-Specific Technology at its expense, provided that if Isis . If the Continuing Party elects not (a) to pursue the filing, prosecution or maintenance of such a Joint Patent in a particular country, or (b) to take any other action with respect to such Joint Patent in a particular country that is necessary or reasonably useful to establish or preserve rights thereto, then in each such case Isis the Continuing Party will so notify OncoGenex the other Party promptly in writing and in good time to enable OncoGenex such Party to meet any deadlines by which an action must be taken to establish or preserve any rights in such Joint Technology in such country, and OncoGenex such Party will have the right, but not the obligation, to pursue the filing or registration, or support the continued prosecution or maintenance, of such Joint Patent, at its expense in such country.

Filing of Joint Patents. The Subject to Section 7.2.5, the Parties will cooperate with one another with respect to the filing, prosecution and maintenance of all Joint Patents. The Parties will designate one of the Parties to be responsible for, and to initially bear the expense of, the preparation, filing, prosecution, and maintenance of a Joint Patent, provided that the responsible Party will be entitled to reimbursement by the other Party of an equal share of the responsible Party’s expenses. The Parties agree that for all 's expenses as follows: i) Proportionate Share of such expenses if the Joint Patents for Patent is a Product-Specific TechnologyTechnology Patent, OncoGenex will be deemed to be the responsible Party for the purposes of this Section 6.2.3, and will bear all expenses for the preparation, filing, prosecution and maintenance or ii) equal sharing of such Patents. With expenses if the exception of Joint Patent to is not a Product-Specific Technology, which will be as set forth in Section 6.2.2, the Technology Patent. The responsible Party will consult with the other Party as to the preparation, filing, prosecution, and maintenance of such Joint Patent reasonably prior to any deadline or action with the U.S. Patent & Trademark Office or any foreign patent office, and will furnish to the other Party party copies of all relevant documents reasonably in advance of such consultation. For the life of the Joint Patents, the Parties will mutually agree upon all Joint Patent filings. Notwithstanding Not withstanding the foregoing, if Isis one Party is unilaterally developing and commercializing the Product in accordance with Section 9.22.3.4, Isis section 2.3.5, or Section 2.4.3, or Article 9, the Party continuing with the development and commercialization of the Product (for purposes of this Section only, the "Continuing Party") will have the first right to file, prosecute and maintain any Joint Patents to Product-Specific Technology at its expense, provided that if Isis . If the Continuing Party elects not (a) to pursue the filing, prosecution or maintenance of such a Joint Patent in a particular country, or (b) to take any other action with respect to such Joint Patent in a particular country that is necessary or reasonably useful to establish or preserve rights thereto, then in each such case Isis the Continuing Party will so notify OncoGenex the other Party promptly in writing and in good time to enable OncoGenex such Party to meet any deadlines by which an action must be taken to establish or preserve any rights in such Joint Technology in such country, and OncoGenex such Party will have the right, but not the obligation, to pursue the filing or registration, or support the continued prosecution or maintenance, of such Joint Patent, at its expense in such country.